Edap Tms (NASDAQ:EDAP) Downgraded to Sell at ValuEngine

ValuEngine downgraded shares of Edap Tms (NASDAQ:EDAP) from a hold rating to a sell rating in a report released on Wednesday morning, ValuEngine reports.

Other analysts have also recently issued reports about the stock. HC Wainwright reiterated a buy rating and issued a $6.50 target price on shares of Edap Tms in a research note on Friday, November 15th. Zacks Investment Research upgraded shares of Edap Tms from a hold rating to a buy rating and set a $5.00 price target for the company in a research report on Friday, January 3rd.

Shares of NASDAQ EDAP traded down $0.03 during mid-day trading on Wednesday, hitting $4.16. The company had a trading volume of 1,465 shares, compared to its average volume of 95,533. Edap Tms has a 1 year low of $2.40 and a 1 year high of $5.42. The company has a market capitalization of $118.90 million, a price-to-earnings ratio of 208.50 and a beta of 1.62. The stock’s 50-day moving average price is $4.56 and its 200-day moving average price is $4.00.

Edap Tms (NASDAQ:EDAP) last issued its earnings results on Wednesday, November 13th. The medical equipment provider reported $0.03 EPS for the quarter, missing the consensus estimate of $0.04 by ($0.01). Edap Tms had a return on equity of 40.29% and a net margin of 7.61%. The company had revenue of $11.35 million during the quarter, compared to the consensus estimate of $13.15 million. As a group, research analysts forecast that Edap Tms will post 0.14 earnings per share for the current year.

Hedge funds and other institutional investors have recently bought and sold shares of the company. Russell Investments Group Ltd. increased its stake in Edap Tms by 168.4% in the third quarter. Russell Investments Group Ltd. now owns 7,332 shares of the medical equipment provider’s stock valued at $33,000 after acquiring an additional 4,600 shares during the last quarter. Morgan Stanley increased its stake in Edap Tms by 222.7% in the 2nd quarter. Morgan Stanley now owns 267,408 shares of the medical equipment provider’s stock worth $722,000 after purchasing an additional 184,539 shares during the period. Commonwealth Equity Services LLC lifted its position in Edap Tms by 25.0% in the third quarter. Commonwealth Equity Services LLC now owns 32,540 shares of the medical equipment provider’s stock valued at $146,000 after purchasing an additional 6,500 shares during the last quarter. JPMorgan Chase & Co. bought a new stake in Edap Tms in the second quarter valued at approximately $282,000. Finally, Susquehanna International Group LLP boosted its stake in shares of Edap Tms by 762.9% during the second quarter. Susquehanna International Group LLP now owns 205,178 shares of the medical equipment provider’s stock valued at $556,000 after purchasing an additional 181,401 shares during the period. 12.04% of the stock is owned by institutional investors.

Edap Tms Company Profile

EDAP TMS SA, together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally-invasive medical devices for the treatment of urological diseases worldwide. The company operates in two divisions: High Intensity Focused Ultrasound (HIFU), and Urology Devices and Services (UDS).

Further Reading: What is the outlook for the FAANG stocks?

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for Edap Tms Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Edap Tms and related companies with MarketBeat.com's FREE daily email newsletter.